|
Volumn 45, Issue 4, 2002, Pages 296-302
|
Male breast carcinoma
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANABOLIC AGENT;
CIMETIDINE;
CYCLOPHOSPHAMIDE;
DIAZEPAM;
DOXORUBICIN;
ESTROGEN;
FLUOROURACIL;
METHOTREXATE;
OMEPRAZOLE;
SPIRONOLACTONE;
TAMOXIFEN;
THIAZIDE DIURETIC AGENT;
TRICYCLIC ANTIDEPRESSANT AGENT;
AGE;
ALGORITHM;
ASPIRATION BIOPSY;
BREAST CARCINOMA;
CANCER DIAGNOSIS;
CANCER EPIDEMIOLOGY;
CANCER INCIDENCE;
CANCER RADIOTHERAPY;
CANCER RISK;
CLINICAL FEATURE;
ENVIRONMENTAL FACTOR;
EPIDEMIOLOGICAL DATA;
ETHNOLOGY;
FAMILY HISTORY;
GYNECOMASTIA;
HISTOLOGY;
HUMAN;
KLINEFELTER SYNDROME;
MAMMOGRAPHY;
MASTECTOMY;
MEDLINE;
MOLECULAR GENETICS;
PROGNOSIS;
RACE;
REVIEW;
RISK ASSESSMENT;
SOCIOECONOMICS;
TREATMENT OUTCOME;
ALGORITHMS;
BREAST NEOPLASMS, MALE;
COMBINED MODALITY THERAPY;
HUMANS;
MALE;
MASTECTOMY, MODIFIED RADICAL;
MIDDLE AGED;
PROGNOSIS;
RISK FACTORS;
|
EID: 0036322409
PISSN: 0008428X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (38)
|
References (50)
|